GCA
MRK icon

Greenwood Capital Associates’s Merck MRK Stock Holding History

Greenwood Capital Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
9,775
-217
-2% -$25.4K 0.12% 144
2026
Q1 		$1.2M Sell
9,992
-354
-3% -$40.9K 0.13% 136
2025
Q4 		$1.09M Buy
+10,346
New +$971K 0.12% 142
2025
Q2 		– Sell
-76,249
Closed -$6.84M – 259
2025
Q1 		$6.84M Buy
+76,249
New +$7.12M 0.92% 31
2024
Q4 		– Sell
-1,926
Closed -$219K – 253
2024
Q3 		$219K Sell
1,926
-12,305
-86% -$1.46M 0.03% 228
2024
Q2 		$1.76M Sell
14,231
-590
-4% -$76K 0.23% 98
2024
Q1 		$1.96M Sell
14,821
-823
-5% -$101K 0.26% 87
2023
Q4 		$1.71M Buy
15,644
+1,823
+13% +$189K 0.22% 91
2023
Q3 		$1.42M Buy
13,821
+110
+0.8% +$11.9K 0.21% 96
2023
Q2 		$1.58M Sell
13,711
-597
-4% -$67.8K 0.22% 92
2023
Q1 		$1.52M Sell
14,308
-434
-3% -$46.9K 0.22% 96
2022
Q4 		$1.64M Buy
14,742
+322
+2% +$32.9K 0.27% 77
2022
Q3 		$1.24M Buy
14,420
+470
+3% +$42K 0.21% 91
2022
Q2 		$1.27M Buy
13,950
+12,668
+988% +$1.12M 0.2% 90
2022
Q1 		$105K Sell
1,282
-9,895
-89% -$780K 0.03% 152
2021
Q4 		$856K Buy
11,177
+1,804
+19% +$144K 0.12% 146
2021
Q3 		$704K Buy
+9,373
New +$713K 0.11% 150
2021
Q1 		– Sell
-64,138
Closed -$5.01M – 228
2020
Q4 		$5.01M Buy
64,138
+947
+1% +$72.4K 0.84% 41
2020
Q3 		$5M Buy
63,191
+5,237
+9% +$410K 0.97% 41
2020
Q2 		$4.28M Buy
57,954
+1,415
+3% +$107K 0.98% 41
2020
Q1 		$4.15M Sell
56,539
-18,940
-25% -$1.49M 1.22% 36
2019
Q4 		$6.55M Sell
75,479
-712
-0.9% -$58.5K 1.38% 22
2019
Q3 		$6.12M Buy
76,191
+4,469
+6% +$358K 1.49% 23
2019
Q2 		$5.74M Buy
+71,722
New +$5.49M 1.44% 25
2014
Q4 		– Sell
-45,067
Closed -$2.55M – 165
2014
Q3 		$2.55M Buy
+45,067
New +$2.53M 0.78% 54
2013
Q4 		– Sell
-53,570
Closed -$2.43M – 114
2013
Q3 		$2.43M Buy
53,570
+1,456
+3% +$66.5K 0.86% 49
2013
Q2 		$2.31M Buy
+52,114
New +$2.33M 1% 41

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Greenwood Capital Associates's MRK Position: Q2 2026 in Review

Greenwood Capital Associates reduced its Merck (MRK) stake by 2.2% in Q2 2026, selling an estimated $25.4K and leaving 9,775 shares worth $1.26M. The position accounts for 0.12% of the portfolio, ranked #144.

Greenwood Capital Associates first reported a position in MRK in Q2 2013 and has held it in 27 quarters since. The position peaked at $6.84M in Q1 2025. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Greenwood Capital Associates held 9,775 shares of Merck worth $1.26M as of Q2 2026.
  • Greenwood Capital Associates sold 217 Merck shares in Q2 2026, an estimated $25.4K.
  • Merck made up 0.12% of Greenwood Capital Associates's portfolio in Q2 2026, its #144 holding.
  • Greenwood Capital Associates first reported a position in Merck in Q2 2013 and has held it in 27 quarters since.
  • Greenwood Capital Associates's Merck position peaked at $6.84M in Q1 2025.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.